Unjha Formulations Ltd

UNJHAFOR

Watchlist

AI Mode

‌

Market Cap

₹ 11 Cr

P/E

10.95

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Unjha Formulations Ltd is a prominent manufacturer of pharmaceutical formulations including liquids, powders, tablets, capsules, and injectables. They are pioneers in Ayurvedic Isabgol products.

The company operates two major divisions for human and veterinary products, making it one of the largest Isabgol product manufacturers in India.

It possesses a state-of-the-art manufacturing facility certified with a GMP certificate, ensuring high-quality production standards.

Unjha Formulations Ltd has successfully tapped into export markets, contributing to its growth, with a new direction in areas like Ferrous Sulphate and Iron Folic Tablets.

A notable strategic move includes their manufacturing agreement with Nicholas Piramal India Ltd for Fybogel, indicating strategic partnership capabilities.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

11 Cr

Volatility

Low Risk

P/E Ratio

11.0

Industry P/E

43.8

PEG Ratio

0.6

P/B Ratio

2.6

52W High

35.18

52W Low

19.99

Sales CAGR

-25.08%

-0.72%

5.51%

10Y

3.28%

Profit CAGR

46.43%

17.30%

5.73%

10Y

5.24%

ROE

TTM

23.59%

11.63%

10.67%

10Y

14.83%

ROCE

TTM

26.37%

17.10%

17.16%

10Y

21.01%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
COLINZ	49.00	22 Cr	48.65	1.88	0.00	4.69	5.88	3.79
DESHRAK	33.77	19 Cr	29.37	1.52	0.00	5.08	7.80	3.39
ZENITHHE	3.48	19 Cr	—	2.46	0.00	-0.79	1.96	-0.56
UNJHAFOR	25.47	11 Cr	10.95	2.59	0.00	23.59	26.37	15.81
GANGAPHARM	11.68	7 Cr	89.85	0.86	0.00	0.96	2.20	0.79
ADLINE	7.98	5 Cr	—	0.00	0.00	2.30	33.90	-25.00
ADVIKLA	1.77	3 Cr	—	5.24	0.00	-138.58	-10.61	-9.90

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	3.76	4.76	5.55	4.43	3.95	3.78	3.76	2.37	3.61	4.29
Expenses	3.55	4.87	5.13	4.37	3.23	3.89	3.53	2.70	3.21	3.50
Operating Profit	0.21	-0.11	0.42	0.06	0.72	-0.11	0.23	-0.33	0.40	0.79
OPM %	5.59	-2.31	7.57	1.35	18.23	-2.91	6.12	-13.92	11.08	18.41
Other Income	-0.01	0.01	0.00	0.01	0.00	0.02	0.01	0.07	0.02	0.06
Interest	0.02	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03
Profit Before Tax	0.18	-0.12	0.39	0.00	0.70	-0.11	0.22	-0.29	0.39	0.82
Tax %	0.00	0.00	0.00	—	0.00	0.00	0.00	-41.38	0.00	0.00
Net Profit	0.18	-0.12	0.39	-0.18	0.70	-0.11	0.22	-0.41	0.39	0.82
EPS in Rs	0.40	0.14	0.87	-0.39	1.56	-0.02	0.50	-0.91	0.90	1.83

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	12	11	11	11	9.96	14	13	18	14	14
Expenses	12	11	11	10	9.82	14	13	18	13	13
Operating Profit	0.38	0.34	0.30	0.25	0.14	0.32	0.43	0.58	0.52	0.19
OPM %	3.09	3.04	2.62	2.34	1.40	2.27	3.29	3.11	3.72	1.41
Other Income	0.11	0.04	0.10	0.26	0.22	0.19	0.03	0.01	0.11	0.12
Interest	0.10	0.02	0.01	0.12	0.17	0.13	0.06	0.05	0.01	0.00
Depreciation	0.09	0.10	0.09	0.08	0.08	0.08	0.08	0.08	0.10	0.10
Profit Before Tax	0.30	0.26	0.30	0.31	0.10	0.30	0.33	0.45	0.52	0.21
Tax %	0.00	0.00	0.00	0.00	0.00	15.72	14.29	38.49	22.16	57.14
Net Profit	0.30	0.26	0.30	0.31	0.10	0.25	0.28	0.28	0.41	0.09
EPS in Rs	0.66	0.56	0.68	0.69	0.23	0.56	0.62	1.02	1.13	2.32
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48
Reserves	-3.83	-3.54	-3.27	-2.97	-2.67	-2.56	-2.31	-2.03	-1.75	-1.34
Borrowings	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	2.28	2.79	2.75	2.15	1.90	1.61	1.28	0.96	2.20	1.42
Total Liabilities	2.93	3.78	3.96	3.65	3.72	3.53	3.45	3.41	4.93	4.56
Fixed Assets	1.03	1.22	1.16	1.12	1.14	1.12	1.07	1.10	1.12	1.20
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1.90	2.55	2.80	2.54	2.57	2.40	2.38	2.31	3.81	3.35
Total Assets	2.93	3.78	3.96	3.65	3.72	3.53	3.45	3.41	4.93	4.56

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.41	0.39	0.14	-0.12	0.39	-0.70	0.28	-0.26	1.03	-0.04
Cash from Investing Activity	-0.02	-0.28	0.06	0.04	-0.10	-0.06	-0.02	-0.10	-0.11	-0.18
Cash from Financing Activity	-0.40	0.05	-0.05	0.23	0.00	0.00	0.00	-0.06	-0.05	-0.01
Net Cash Flow	-0.01	0.15	0.15	0.16	0.29	-0.77	0.25	-0.42	0.86	-0.23

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%	36.92%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	63.08%	62.96%	63.08%	63.08%	63.08%	63.08%	63.08%	63.08%	63.08%	63.08%	63.08%	63.08%
Total Shareholders	4,018	3,993	3,963	3,993	4,012	3,933	3,985	3,969	4,208	4,273	4,213	4,284

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Aug 07, 2024	Multiplier share & stock advi...	Bulk	Sell	28.32	0.07 Cr	25,515	0.56
Aug 07, 2024	Multiplier share & stock advi...	Bulk	Buy	28.32	0.06 Cr	20,161	0.44
Feb 06, 2024	Satya prakash mittal huf	Bulk	Buy	22.52	0.06 Cr	27,333	0.61
May 25, 2023	Krutiben mayankkumar patel	Insider - Connected Person	Acquisition	—	—	5,65,751	12.6
Mar 15, 2023	Krutiben mayankkumar patel	Insider - Connected Person	Acquisition	0.00	0.00 Cr	5,65,751	12.6

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
COLINZ	49.00	22 Cr	48.65	1.88	0.00	4.69	5.88	3.79
DESHRAK	33.77	19 Cr	29.37	1.52	0.00	5.08	7.80	3.39
ZENITHHE	3.48	19 Cr	—	2.46	0.00	-0.79	1.96	-0.56
UNJHAFOR	25.47	11 Cr	10.95	2.59	0.00	23.59	26.37	15.81
GANGAPHARM	11.68	7 Cr	89.85	0.86	0.00	0.96	2.20	0.79
ADLINE	7.98	5 Cr	—	0.00	0.00	2.30	33.90	-25.00
ADVIKLA	1.77	3 Cr	—	5.24	0.00	-138.58	-10.61	-9.90

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	3.76	4.76	5.55	4.43	3.95	3.78	3.76	2.37	3.61	4.29
Expenses	3.55	4.87	5.13	4.37	3.23	3.89	3.53	2.70	3.21	3.50
Operating Profit	0.21	-0.11	0.42	0.06	0.72	-0.11	0.23	-0.33	0.40	0.79
OPM %	5.59	-2.31	7.57	1.35	18.23	-2.91	6.12	-13.92	11.08	18.41
Other Income	-0.01	0.01	0.00	0.01	0.00	0.02	0.01	0.07	0.02	0.06
Interest	0.02	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03
Profit Before Tax	0.18	-0.12	0.39	0.00	0.70	-0.11	0.22	-0.29	0.39	0.82
Tax %	0.00	0.00	0.00	—	0.00	0.00	0.00	-41.38	0.00	0.00
Net Profit	0.18	-0.12	0.39	-0.18	0.70	-0.11	0.22	-0.41	0.39	0.82
EPS in Rs	0.40	0.14	0.87	-0.39	1.56	-0.02	0.50	-0.91	0.90	1.83

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	12	11	11	11	9.96	14	13	18	14	14
Expenses	12	11	11	10	9.82	14	13	18	13	13
Operating Profit	0.38	0.34	0.30	0.25	0.14	0.32	0.43	0.58	0.52	0.19
OPM %	3.09	3.04	2.62	2.34	1.40	2.27	3.29	3.11	3.72	1.41
Other Income	0.11	0.04	0.10	0.26	0.22	0.19	0.03	0.01	0.11	0.12
Interest	0.10	0.02	0.01	0.12	0.17	0.13	0.06	0.05	0.01	0.00
Depreciation	0.09	0.10	0.09	0.08	0.08	0.08	0.08	0.08	0.10	0.10
Profit Before Tax	0.30	0.26	0.30	0.31	0.10	0.30	0.33	0.45	0.52	0.21
Tax %	0.00	0.00	0.00	0.00	0.00	15.72	14.29	38.49	22.16	57.14
Net Profit	0.30	0.26	0.30	0.31	0.10	0.25	0.28	0.28	0.41	0.09
EPS in Rs	0.66	0.56	0.68	0.69	0.23	0.56	0.62	1.02	1.13	2.32
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48	4.48
Reserves	-3.83	-3.54	-3.27	-2.97	-2.67	-2.56	-2.31	-2.03	-1.75	-1.34
Borrowings	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	2.28	2.79	2.75	2.15	1.90	1.61	1.28	0.96	2.20	1.42
Total Liabilities	2.93	3.78	3.96	3.65	3.72	3.53	3.45	3.41	4.93	4.56
Fixed Assets	1.03	1.22	1.16	1.12	1.14	1.12	1.07	1.10	1.12	1.20
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1.90	2.55	2.80	2.54	2.57	2.40	2.38	2.31	3.81	3.35
Total Assets	2.93	3.78	3.96	3.65	3.72	3.53	3.45	3.41	4.93	4.56

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.41	0.39	0.14	-0.12	0.39	-0.70	0.28	-0.26	1.03	-0.04
Cash from Investing Activity	-0.02	-0.28	0.06	0.04	-0.10	-0.06	-0.02	-0.10	-0.11	-0.18
Cash from Financing Activity	-0.40	0.05	-0.05	0.23	0.00	0.00	0.00	-0.06	-0.05	-0.01
Net Cash Flow	-0.01	0.15	0.15	0.16	0.29	-0.77	0.25	-0.42	0.86	-0.23

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

Unjha Formulations Ltd is a prominent manufacturer of pharmaceutical formulations including liquids, powders, tablets, capsules, and injectables. They are pioneers in Ayurvedic Isabgol products.

The company operates two major divisions for human and veterinary products, making it one of the largest Isabgol product manufacturers in India.

It possesses a state-of-the-art manufacturing facility certified with a GMP certificate, ensuring high-quality production standards.

Unjha Formulations Ltd has successfully tapped into export markets, contributing to its growth, with a new direction in areas like Ferrous Sulphate and Iron Folic Tablets.

A notable strategic move includes their manufacturing agreement with Nicholas Piramal India Ltd for Fybogel, indicating strategic partnership capabilities.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

11 Cr

Volatility

Low Risk

P/E Ratio

11.0

Industry P/E

43.8

PEG Ratio

0.6

P/B Ratio

2.6

52W High

35.18

52W Low

19.99

Sales CAGR

-25.08%

-0.72%

5.51%

10Y

3.28%

Profit CAGR

46.43%

17.30%

5.73%

10Y

5.24%

ROE

TTM

23.59%

11.63%

10.67%

10Y

14.83%

ROCE

TTM

26.37%

17.10%

17.16%

10Y

21.01%